These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 25887385

  • 21. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K, Drew R.
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [Abstract] [Full Text] [Related]

  • 22. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 23. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX, Shen JL, Tang XF, Feng B.
    Transplant Proc; 2013 Jul; 45(1):407-14. PubMed ID: 23375330
    [Abstract] [Full Text] [Related]

  • 24. Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
    Gonzalez AV, Ullmann AJ, Almyroudis NG, Segal BH.
    J Natl Compr Canc Netw; 2008 Feb; 6(2):175-82. PubMed ID: 18319049
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH, Kan LP, Lin HA, Chang FY, Wang NC, Lin TY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC.
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [Abstract] [Full Text] [Related]

  • 27. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
    van Burik JA.
    Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Invasive fungal infection in haematology patients].
    Vallejo Llamas JC, Ruiz-Camps I.
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.
    Cancer; 2002 Jun 15; 94(12):3230-46. PubMed ID: 12115356
    [Abstract] [Full Text] [Related]

  • 35. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG, Webster AC, Sorrell TC, Craig JC.
    J Antimicrob Chemother; 2006 Apr 15; 57(4):628-38. PubMed ID: 16459344
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patients at high risk of invasive fungal infections: when and how to treat.
    Rüping MJ, Vehreschild JJ, Cornely OA.
    Drugs; 2008 Apr 15; 68(14):1941-62. PubMed ID: 18778118
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.